| Trade name of the product: |
| Recormon PS |
| Pharmaceutical active ingredients: |
| Epoetin Beta |
| Available forms, composition and doses of Recormon PS: |
| Injectable; Injection; Epoetin Beta 10,000 IUInjectable; Injection; Epoetin Beta 1000 IUInjectable; Injection; Epoetin Beta 2,000 IUInjectable; Injection; Epoetin Beta 3,000 IUInjectable; Injection; Epoetin Beta 30,000 IUInjectable; Injection; Epoetin Beta 4,000 IUInjectable; Injection; Epoetin Beta 5,000 IUInjectable; Injection; Epoetin Beta 6,000 IU |
| Medical categories: |
| Human:Haematopoietic agentsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| B03XA01 - Erythropoietin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Roche |
| Related documents and information about Recormon PS: |
| Recormon prescribing information (PDF) |